Nebula Research & Development LLC Amneal Pharmaceuticals, Inc. Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 56,363 shares of AMRX stock, worth $454,285. This represents 0.04% of its overall portfolio holdings.
Number of Shares
56,363
Previous 46,512
21.18%
Holding current value
$454,285
Previous $368 Million
28.22%
% of portfolio
0.04%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding AMRX
# of Institutions
244Shares Held
135MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$127 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$99.4 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$90.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$86.5 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$60.4 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.22B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...